BRY812

· BioRay Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BRY812, covering 2025-12-30 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies [Phase 2]